Home › Funds › Bellevue Group AG › UTHR

Bellevue Group AG position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

Bellevue Group AG reported holding 188,515 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q2 2026 13F filing — a position valued at US$102.1M, representing 2.15% of its reported portfolio and ranking #13 among its reported holdings. Bellevue Group AG has disclosed UTHR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)188.51K sh
Reported value held$102.14M
Portfolio Weight2.15%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's UTHR position evolved

Bellevue Group AG first disclosed a stake in UTHR in Q3 2025 at 2,640 shares (US$1.1M). The position peaked in Q2 2026 at 188,515 shares, worth US$102.1M. Across 4 filings, Bellevue Group AG increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 188,515 shares valued at US$102.1M — an increase of 186,438 shares quarter over quarter.. Notable position changes include a 48% increase in Q4 2025 (shares rose 22% over the following quarter), a 47% trim in Q1 2026 (shares fell 9% over the following quarter), a 8976% increase in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 2.64K $1.11M New
Q4 2025 3.90K $1.90M Add
Q1 2026 2.08K $1.23M Reduce
Q2 2026 188.51K $102.14M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 43 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has Bellevue Group AG held UTHR?

Bellevue Group AG has disclosed UTHR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Bellevue Group AG's current position in UTHR?

As of Q2 2026, Bellevue Group AG holds 188.51K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $102.14M, representing 2.15% of its reported portfolio and ranking #13.

Has Bellevue Group AG been buying or selling UTHR?

In the latest 13F filing (Q2 2026), Bellevue Group AG increased its position in UTHR. The position peaked in Q2 2026 at 188.51K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.